AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Joakim Tedroff
CMO at IRLAB
Stockholm
Public Documents
2
September 30, 2024
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a...
Abdolaziz Ronaghi, Tiberiu Loredan Stan, Sebastian Barrientos, et al.
October 05, 2020
A first-in-human oral dose study of mesdopetam (IRL790) to assess its safety, tolerab...
Folke Sjoberg, Susanna Waters, Boel Löfberg, et al.